Sustained expression fo human apo A-1 following adenoviral gene transfer in mice

Gene Therapy

Volumn 8, Issue 2, 2001, Pages 121-127

  De Geest, B ^a   Van Linthout, S ^a   Collen, D ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Atherosclerosis; Gene transfer; High density lipoproteins; Immune response

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER PROTEIN; PROTEIN ANTIBODY; VIRUS DNA; ALANINE AMINOTRANSFERASE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA DETERMINATION; GENE CONSTRUCT; GENE EXPRESSION; GENE TRANSFER; GENETIC ANALYSIS; HUMORAL IMMUNITY; IMMUNE RESPONSE; ISCHEMIC HEART DISEASE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; TRANSGENE; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; SPECIES DIFFERENCE; SPLEEN;

ADA; ADENOVIRIDAE; ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES;

ADENOVIRIDAE; ALANINE TRANSAMINASE; ANIMALS; ANTIBODY FORMATION; APOLIPOPROTEIN A-I; CELL DIVISION; CYTOMEGALOVIRUS; DNA; FEMALE; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; PROMOTER REGIONS (GENETICS); SPECIES SPECIFICITY; SPLEEN; TRANSGENES;

EID: 0034746309     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301374     Document Type: Article

References (16)

1. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies
2. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice
3. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse
4. Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice
5. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice
6. Sustained expression of human apolipoprotein A-I following adenoviral gene transfer in C57BL/6 mice. Role of apo A-I promoter, apo A-I introns and human apo E enhancer
7. Sustained expression of therapeutic levels of human factor VIII in mice
8. Adenovirus-mediated gene transfer: Influence of transgene, mouse strain and type of immune response on persistence of transgene expression
9. Strain related variations in adenovirally mediated transgene expression from mousehepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains
10. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: Comparison of E2a wild type and E2a deleted vectors
11. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers
12. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors
13. + T cells
14. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration
15. Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery
16. Evaluation of the concentration and bioactivity of adenovectors for gene therapy